We are just one quarter into 2022 and the Food and Drug Administration (FDA) already has experienced a number of significant changes and developments. A new commissioner has been.
The centrist Democrat said prescription drug prices and tax reform are the two areas the party should target to raise revenue if they’re going to move a party-line bill through the reconciliation process.